Cumberland Pharmaceuticals (CPIX) Total Liabilities (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Total Liabilities of $49.7 million for Q1 2026, down 4.95% sequentially from $52.3 million in Q4 2025, and up 19.47% YoY from $41.6 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Total Liabilities (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Total Liabilities for 17 years, with the latest figure at $49.7 million in Q1 2026.
- Quarterly Total Liabilities rose 19.47% year-over-year to $49.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.7 million (up 19.47% YoY) and the FY2025 annual result came in at $52.3 million, down 1.43% from the prior year.
- Total Liabilities retreated to $49.7 million in Q1 2026 per CPIX's latest filing, from $52.3 million in the prior quarter.
- Over five years, Total Liabilities peaked at $57.0 million in Q4 2022 and troughed at $40.1 million in Q3 2025.
- A 5-year average of $50.9 million and a median of $52.5 million in 2024 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Liabilities soared 36.06% in 2022, then declined 23.43% in 2025.
- Over 5 years, Total Liabilities stood at $57.0 million in 2022, then fell by 7.79% to $52.5 million in 2023, then increased by 0.99% to $53.0 million in 2024, then retreated by 1.43% to $52.3 million in 2025, then fell by 4.95% to $49.7 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $49.7 million, $52.3 million, and $40.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 2.12 Bn |
| 10 | Cumberland Pharmaceuticals | 117.08 Mn | 113.22 Mn | - | 45.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.77 Mn |
| Mar 31, 2026 | 49.69 Mn |
| Dec 31, 2025 | 52.28 Mn |
| Sep 30, 2025 | 40.10 Mn |
| Jun 30, 2025 | 40.23 Mn |
| Mar 31, 2025 | 41.60 Mn |
| Dec 31, 2024 | 53.04 Mn |
| Sep 30, 2024 | 52.28 Mn |
| Jun 30, 2024 | 52.49 Mn |
| Mar 31, 2024 | 54.32 Mn |
| Dec 31, 2023 | 52.52 Mn |
| Sep 30, 2023 | 52.10 Mn |
| Jun 30, 2023 | 52.54 Mn |
| Mar 31, 2023 | 53.42 Mn |
| Dec 31, 2022 | 56.95 Mn |
| Sep 30, 2022 | 52.29 Mn |
| Jun 30, 2022 | 53.31 Mn |
| Mar 31, 2022 | 55.90 Mn |
| Dec 31, 2021 | 41.86 Mn |
| Sep 30, 2021 | 40.92 Mn |